Iranian Red Crescent Medical Journal

Published by: Kowsar

Concentration- and Time-Dependent Cytotoxicity of Silver Nanoparticles on Normal Human Skin Fibroblast Cell Line

Mansoureh Paknejadi 1 , Mansour Bayat 1 , Mona Salimi 2 , * and Vadood Razavilar 1
Authors Information
1 Department of Pathobiology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2018, 20 (10); e79183
  • Published Online: October 16, 2018
  • Article Type: Research Article
  • Received: May 17, 2018
  • Accepted: July 19, 2018
  • DOI: 10.5812/ircmj.79183

To Cite: Paknejadi M, Bayat M, Salimi M, Razavilar V. Concentration- and Time-Dependent Cytotoxicity of Silver Nanoparticles on Normal Human Skin Fibroblast Cell Line, Iran Red Crescent Med J. 2018 ; 20(10):e79183. doi: 10.5812/ircmj.79183.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mukherjee SG, O'Claonadh N, Casey A, Chambers G. Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro. 2012;26(2):238-51. doi: 10.1016/j.tiv.2011.12.004. [PubMed: 22198051].
  • 2. Sambale F, Wagner S, Stahl F, Khaydarov RR, Scheper T, Bahnemann D. Investigations of the toxic effect of silver nanoparticles on mammalian cell lines. J Nanomater. 2015;2015:1-9. doi: 10.1155/2015/136765.
  • 3. Bondarenko O, Juganson K, Ivask A, Kasemets K, Mortimer M, Kahru A. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Arch Toxicol. 2013;87(7):1181-200. doi: 10.1007/s00204-013-1079-4. [PubMed: 23728526]. [PubMed Central: PMC3677982].
  • 4. Zhang XF, Liu ZG, Shen W, Gurunathan S. Silver nanoparticles: Synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci. 2016;17(9). doi: 10.3390/ijms17091534. [PubMed: 27649147]. [PubMed Central: PMC5037809].
  • 5. Shahbazzadeh D, Ahari H, Motalebi AA, Anvar AA, Moaddab S, Asadi T, et al. In vitro effect of nanosilver toxicity on fibroblast and mesenchymal stem cell lines. Iran J Fish Sci. 2011;10(3):487-96.
  • 6. Arif T, Nisa N, Amin SS, Shoib S, Mushtaq R, Shawl MR. Therapeutic and diagnostic applications of nanotechnology in dermatology and cosmetics. J Nanomed Biotherapy Discov. 2015;5(3):134. doi: 10.4172/2155-983X.1000134.
  • 7. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol. 2014;11:11. doi: 10.1186/1743-8977-11-11. [PubMed: 24529161]. [PubMed Central: PMC3933429].
  • 8. Faedmaleki F, H Shirazi F, Salarian AA, Ahmadi Ashtiani H, Rastegar H. Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res. 2014;13(1):235-42. [PubMed: 24734076]. [PubMed Central: PMC3985257].
  • 9. Zapor L. Effects of silver nanoparticles of different sizes on cytotoxicity and oxygen metabolism disorders in both reproductive and respiratory system cells. Arch Environ Prot. 2016;42(4):32-47. doi: 10.1515/aep-2016-0038.
  • 10. Hartemann P, Hoet P, Proykova A, Fernandes T, Baun A, De Jong W, et al. Nanosilver: Safety, health and environmental effects and role in antimicrobial resistance. Mater Today. 2015;18(3):122-3. doi: 10.1016/j.mattod.2015.02.014.
  • 11. Connolly M, Fernandez-Cruz ML, Quesada-Garcia A, Alte L, Segner H, Navas JM. Comparative cytotoxicity study of silver nanoparticles (AgNPs) in a variety of rainbow trout cell lines (RTL-W1, RTH-149, RTG-2) and primary hepatocytes. Int J Environ Res Public Health. 2015;12(5):5386-405. doi: 10.3390/ijerph120505386. [PubMed: 26006119]. [PubMed Central: PMC4454974].
  • 12. McShan D, Ray PC, Yu H. Molecular toxicity mechanism of nanosilver. J Food Drug Anal. 2014;22(1):116-27. doi: 10.1016/j.jfda.2014.01.010. [PubMed: 24673909]. [PubMed Central: PMC4281024].
  • 13. Zhang XF, Shen W, Gurunathan S. Silver nanoparticle-mediated cellular responses in various cell lines: An in vitro model. Int J Mol Sci. 2016;17(10). doi: 10.3390/ijms17101603. [PubMed: 27669221]. [PubMed Central: PMC5085636].
  • 14. Kaiser JP, Roesslein M, Diener L, Wichser A, Nowack B, Wick P. Cytotoxic effects of nanosilver are highly dependent on the chloride concentration and the presence of organic compounds in the cell culture media. J Nanobiotechnology. 2017;15(1):5. doi: 10.1186/s12951-016-0244-3. [PubMed: 28061858]. [PubMed Central: PMC5219688].
  • 15. Carbone M, Donia DT, Sabbatella G, Antiochia R. Silver nanoparticles in polymeric matrices for fresh food packaging. J King Saud Univ Sci. 2016;28(4):273-9. doi: 10.1016/j.jksus.2016.05.004.
  • 16. Peng H, Zhang XF, Wei Y, Liu W, Li S, Yu G, et al. Cytotoxicity of silver nanoparticles in human embryonic stem cell-derived fibroblasts and an L-929 cell line. J Nanomater. 2012;2012:1-9. doi: 10.1155/2012/160145.
  • 17. Heydarnejad MS, Yarmohammadi SP, Mobini DM, Shadkhast M, Rahnama S. Histopathological effects of nanosilver (Ag-NPs) in liver after dermal exposure during wound healing. Nanomedicine. 2014;1(3):191-7. doi: 10.7508/nmj.2014.03.009.
  • 18. Boonkaew B, Kempf M, Kimble R, Supaphol P, Cuttle L. Antimicrobial efficacy of a novel silver hydrogel dressing compared to two common silver burn wound dressings: Acticoat and PolyMem silver((R)). Burns. 2014;40(1):89-96. doi: 10.1016/j.burns.2013.05.011. [PubMed: 23790588].
  • 19. Monteiro DR, Silva S, Negri M, Gorup LF, de Camargo ER, Oliveira R, et al. Silver nanoparticles: Influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms. Lett Appl Microbiol. 2012;54(5):383-91. doi: 10.1111/j.1472-765X.2012.03219.x. [PubMed: 22313289].
  • 20. Monteiro DR, Silva S, Negri M, Gorup LF, de Camargo ER, Oliveira R, et al. Silver colloidal nanoparticles: Effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms. J Appl Microbiol. 2013;114(4):1175-83. doi: 10.1111/jam.12102. [PubMed: 23231706].
  • 21. Monteiro DR, Takamiya AS, Feresin LP, Gorup LF, de Camargo ER, Delbem AC, et al. Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases. J Prosthodont Res. 2015;59(1):42-8. doi: 10.1016/j.jpor.2014.07.004. [PubMed: 25168655].
  • 22. Shaheen TI, Fouda A. Green approach for one-pot synthesis of silver nanorod using cellulose nanocrystal and their cytotoxicity and antibacterial assessment. Int J Biol Macromol. 2018;106:784-92. doi: 10.1016/j.ijbiomac.2017.08.070. [PubMed: 28818719].
  • 23. Zhang Y, Lu H, Yu D, Zhao D. AgNPs and Ag/C225 exert anticancerous effects via cell cycle regulation and cytotoxicity enhancement. J Nanomater. 2017;2017:10.
  • 24. Norouzi S, Norouzi M, Amini M, Amanzadeh A, Nabiuni M, Irian S, et al. Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-kappaB and FHC pathways. Daru. 2016;24:1. doi: 10.1186/s40199-015-0139-0. [PubMed: 26739353]. [PubMed Central: PMC4704250].
  • 25. Tabrizi FH, Irian S, Amanzadeh A, Heidarnejad F, Gudarzi H, Salimi M. Anti-proliferative activity of Fumaria vaillantii extracts on different cancer cell lines. Res Pharm Sci. 2016;11(2):152-9. [PubMed: 27168755]. [PubMed Central: PMC4852660].
  • 26. Jackson JE, Kopecki Z, Cowin AJ. Nanotechnological advances in cutaneous medicine. J Nanomater. 2013;2013:1-8. doi: 10.1155/2013/808234.
  • 27. Kong B, Seog JH, Graham LM, Lee SB. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine (Lond). 2011;6(5):929-41. doi: 10.2217/nnm.11.77. [PubMed: 21793681]. [PubMed Central: PMC3196306].
  • 28. Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009;1(4):197-206. [PubMed: 20592791]. [PubMed Central: PMC2835875].
  • 29. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-90. doi: 10.1021/nn800596w. [PubMed: 19236062].
  • 30. Moaddab S, Ahari H, Shahbazzadeh D, Motallebi AA, Anvar AA, Rahman-Nya J, et al. Toxicity study of nanosilver (nanocid?) on osteoblast cancer cell line. Int Nano Letter. 2011;1(1):11.
  • 31. Chun JY, Kang HK, Jeong L, Kang YO, Oh JE, Yeo IS, et al. Epidermal cellular response to poly(vinyl alcohol) nanofibers containing silver nanoparticles. Colloids Surf B Biointerfaces. 2010;78(2):334-42. doi: 10.1016/j.colsurfb.2010.03.026. [PubMed: 20399628].
  • 32. Dziedzic A, Kubina R, Buldak RJ, Skonieczna M, Cholewa K. Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of berberine. Molecules. 2016;21(3):365. doi: 10.3390/molecules21030365. [PubMed: 26999092].
  • 33. Ivask A, Kurvet I, Kasemets K, Blinova I, Aruoja V, Suppi S, et al. Size-dependent toxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro. PLoS One. 2014;9(7). e102108. doi: 10.1371/journal.pone.0102108. [PubMed: 25048192]. [PubMed Central: PMC4105572].
  • 34. Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, et al. Impact of silver nanoparticles on human cells: Effect of particle size. Nanotoxicology. 2010;4(3):319-30. doi: 10.3109/17435390.2010.483745. [PubMed: 20795913].
  • 35. Bressan E, Ferroni L, Gardin C, Rigo C, Stocchero M, Vindigni V, et al. Silver nanoparticles and mitochondrial interaction. Int J Dent. 2013;2013:312747. doi: 10.1155/2013/312747. [PubMed: 24101927]. [PubMed Central: PMC3786470].
  • 36. Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA. Silver nanoparticle protein corona composition in cell culture media. PLoS One. 2013;8(9). e74001. doi: 10.1371/journal.pone.0074001. [PubMed: 24040142]. [PubMed Central: PMC3767594].
  • 37. Pratsinis A, Hervella P, Leroux JC, Pratsinis SE, Sotiriou GA. Toxicity of silver nanoparticles in macrophages. Small. 2013;9(15):2576-84. doi: 10.1002/smll.201202120. [PubMed: 23418027].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments